2-(2-Methoxyphenoxy)ethylamine Hydrochloride Hydrate CAS 64464-07-9 Carvedilol Intermediate Purity ≥98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of 2-(2-Methoxyphenoxy)ethylamine Hydrochloride Hydrate (CAS: 64464-07-9) with high quality. Ruifu can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Welcome to place an order, Please contact: alvin@ruifuchem.com
Related Intermediates of Carvedilol
Chemical Name | 2-(2-Methoxyphenoxy)ethylamine Hydrochloride Hydrate |
Synonyms | 1-(2-Aminoethoxy)-2-Methoxybenzene Hydrochloride Hydrate;2-(2-Aminoethoxy)anisole Hydrochloride Hydrate |
Impurity | Carvedilol USP Related Compound E; Carvedilol EP Impurity E |
Stock Status | In Stock |
CAS Number | 64464-07-9 |
Molecular Formula | C9H13NO2·HCl·H2O |
Molecular Weight | 221.68 g/mol |
Melting Point | 88.0~92.0℃ |
Solubility in Hot Water | Almost Transparency |
Storage Temp. | Cool & Dry Place (2~8℃) |
COA & MSDS | Available |
Brand | Ruifu Chemical |
Hazard Codes | Xi - Irritant | ||
WGK Germany | 3 | ||
Hazard Class | IRRITANT |
Items | Inspection Standards |
Appearance | White Crystalline Powder |
Melting Point | 88.0~92.0℃ |
Water by Karl Fischer | ≤10.0% |
Residual Solvents | ≤5.0% |
Purity / Analysis Method | ≥98.0% (HPLC) |
Purity / Analysis Method | ≥98.0% (Argentmetric Titration) |
Infrared Spectrum | Conforms to Structure |
1 H NMR Spectrum | Conforms to Structure |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Store in a tightly closed container. Store in a cool, dry (2~8℃) and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
2-(2-Methoxyphenoxy)ethylamine Hydrochloride Hydrate (CAS: 64464-07-9) is an intermediate or impurity of Carvedilol (CAS: 72956-09-3). Carvedilol was first launched in Belgium in 1985. This product can block alpha and beta receptors, no intrinsic activity, in high concentrations of fashion with calcium antagonism. It has a strong effect of blocking beta receptors, which can expand blood vessels, reduce peripheral resistance and lower blood pressure, and has little effect on cardiac output and heart rate. Clinical can be used for primary hypertension and angina pectoris. The initial dose is 25mg 1 day, 1 time, according to the need to increase the dose to 1 day 50mg, divided into 1~2 times, the maximum daily dose does not exceed 100mg. After taking common adverse reactions were dizziness, Head Pain, Fatigue, bradycardia can occur. Chronic obstructive pulmonary disease patients, diabetic patients, liver function, pregnant women and lactating women disabled.